Assembly Biosciences
ASMB • NASDAQ
Assembly Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jason A. Okazaki, with a market cap of $473.5M.
Market Cap$473.5M
Employees65.0
CEOJason A. Okazaki
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Assembly Biosciences FAQ
Common questions about Assembly Biosciences
Assembly Biosciences is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $7.8M.
Assembly Biosciences has approximately 65 employees.